Related references
Note: Only part of the references are listed.CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway
Hiroaki Yasui et al.
CLINICAL & EXPERIMENTAL METASTASIS (2020)
Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis
Toni Celia-Terrassa et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells
Ran Cheng et al.
ONCOGENE (2020)
CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH-NF-κB signalling pathway
Yuexiang Qin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
IL-8 and CXCR1 expression is associated with cancer stem cell-like properties of clear cell renal cancer
Claudia Corro et al.
JOURNAL OF PATHOLOGY (2019)
Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo
Guangchen Liu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Meta-analysis of the prognostic value of C-C chemokine receptor type 7 in patients with solid tumors
Guangchen Zu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Exploring the complex role of chemokines and chemoattractants in vivo on leukocyte dynamics
Bruna A. David et al.
IMMUNOLOGICAL REVIEWS (2019)
CCL2 promotes cell migration by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma
Zihang Ling et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2019)
Influence of Interleukin-8 and Neutrophil Extracellular Trap (NET) Formation in the Tumor Microenvironment: Is There a Pathogenic Role?
Manuela Gonzalez-Aparicio et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
The B-Side of Cancer Immunity: The Underrated Tune
Anne Largeot et al.
CELLS (2019)
Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis
Zulei Zhang et al.
CANCER BIOLOGY & THERAPY (2019)
CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
Yongning Lu et al.
CELL COMMUNICATION AND SIGNALING (2019)
Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor-associated macrophages
Gaili An et al.
ONCOLOGY REPORTS (2019)
NF-κB Dependent Chemokine Signaling in Pancreatic Cancer
Claudia Geismann et al.
CANCERS (2019)
CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion
Junhee Park et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis
Mengxuan Zhu et al.
CELL DEATH & DISEASE (2019)
Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma
Yan-Li Li et al.
ANNALS OF HEMATOLOGY (2019)
Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization
Elisabetta Marcuzzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis
Xiaolei Jiao et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2019)
Getting TANned: How the tumor microenvironment drives neutrophil recruitment
Shuvasree SenGupta et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation
Min Yao et al.
MOLECULAR CANCER RESEARCH (2019)
Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
Valeria Mollica Poeta et al.
FRONTIERS IN IMMUNOLOGY (2019)
Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy
Anna E. Vilgelm et al.
FRONTIERS IN IMMUNOLOGY (2019)
Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms
Gage Brummer et al.
MOLECULAR CANCER RESEARCH (2018)
Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach
Hadi Rezaeeyan et al.
APMIS (2018)
Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence
Antero Salminen et al.
BIOGERONTOLOGY (2018)
Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report
Ivana N. Micallef et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer
Changhua Zhuo et al.
BIOSCIENCE REPORTS (2018)
CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes
Younghun Jung et al.
CANCER RESEARCH (2018)
CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion
Xuanmao Jiao et al.
CANCER RESEARCH (2018)
Tumor associated macrophages in gynecologic cancers
Venkatesh Krishnan et al.
GYNECOLOGIC ONCOLOGY (2018)
Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation
Shigeo Fuji et al.
HAEMATOLOGICA (2018)
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
Jinyang Li et al.
IMMUNITY (2018)
CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
Santosh Kumar Singh et al.
SCIENTIFIC REPORTS (2018)
Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation
Shigeo Fuji et al.
HAEMATOLOGICA (2018)
Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
Mieke Metzemaekers et al.
FRONTIERS IN IMMUNOLOGY (2018)
Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies
Peng-Fei Wang et al.
ONCOIMMUNOLOGY (2018)
T-Helper 1 Immune Response in Metastatic Lymph Nodes of Pancreatic Ductal Adenocarcinoma: A Marker For Prolonged Survival
Eran Nizri et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma
Anusha Kalbasi et al.
CLINICAL CANCER RESEARCH (2017)
Criteria derived from serum markers can precisely evaluate axillary status in breast cancer patients
Hangyu Wan et al.
JOURNAL OF SURGICAL RESEARCH (2017)
Chemokine (C-C motif) ligand 21/C-C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial-mesenchymal transition via the extracellular signal-regulated kinase signaling pathway
Guangxin Zhong et al.
MOLECULAR MEDICINE REPORTS (2017)
Integrated analysis of mRNA and miRNA expression profiles in pancreatic ductal adenocarcinoma
Hongwei Sun et al.
ONCOLOGY REPORTS (2017)
CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway
Tao Shen et al.
ONCOLOGY REPORTS (2017)
TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma
Xin Zhang et al.
TUMOR BIOLOGY (2017)
CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma
Hongfang Zhang et al.
CELL DEATH & DISEASE (2017)
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
Geny Piro et al.
ONCOIMMUNOLOGY (2017)
Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma
Rahima Jamal et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
The clinical and prognostic value of CXCL8 in cervical carcinoma patients: immunohistochemical analysis
Ruiling Yan et al.
BIOSCIENCE REPORTS (2017)
The prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study
Cesar Homero Gutierrez-Aguirre et al.
ANNALS OF HEMATOLOGY (2017)
Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway
LiYa Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells
Hui Wang et al.
CELL BIOCHEMISTRY AND FUNCTION (2017)
CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer
Dingzhi Wang et al.
CANCER RESEARCH (2017)
CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma
Yusuke Sato et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer
Nisha Nagarsheth et al.
CANCER RESEARCH (2016)
CCL20-CCR6 Cytokine Network Facilitate Treg Activity in Advanced Grades and Metastatic Variants of Hepatocellular Carcinoma
W. -M. Li et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2016)
CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma
Kexin Li et al.
TUMOR BIOLOGY (2016)
CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway
Jing Yang et al.
ONCOTARGET (2016)
CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis
Yusuke Uchi et al.
BMC CANCER (2016)
Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils
Yanfang Liu et al.
CANCER CELL (2016)
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W. Steele et al.
CANCER CELL (2016)
Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination
Jason S. L. Yu et al.
DEVELOPMENT (2016)
Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer
Maria Rosaria Galdiero et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis
Marina Lesina et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Analysis of histological and immunological parameters of metastatic lymph nodes from colon cancer patients reveals that T-helper 1 type immune response is associated with improved overall survival
Eran Nizri et al.
MEDICINE (2016)
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
Anne M. Noonan et al.
MOLECULAR THERAPY (2016)
Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer
Sebastian Lundgren et al.
JOURNAL OF OVARIAN RESEARCH (2016)
Prognostic value of tumor infiltrating NK cells and macrophages in stage II plus III esophageal cancer patients
Bin Xu et al.
ONCOTARGET (2016)
Targeting the CCL2-CCR2 signaling axis in cancer metastasis
Su Yin Lim et al.
ONCOTARGET (2016)
Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma
Ilona Kryczek et al.
ONCOIMMUNOLOGY (2016)
Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting
Diether Lambrechts et al.
BRITISH JOURNAL OF CANCER (2015)
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
Takanori Kitamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Dongjun Peng et al.
NATURE (2015)
CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells
Miao Mo et al.
PLOS ONE (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition
Ke-Zhu Hou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy
Shintaro Tsukinaga et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma
Fei Hu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma
Yi Li et al.
ONCOTARGET (2015)
Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma
Jinyan Liu et al.
ONCOTARGET (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
Tertiary lymphoid structure-associated B cells are key players in anti-tumor immunity
Claire Germain et al.
FRONTIERS IN IMMUNOLOGY (2015)
Tissue Inhibitor of Metalloproteinases (TIMP)-1 Creates a Premetastatic Niche in the Liver Through SDF-1/CXCR4-Dependent Neutrophil Recruitment in Mice
Bastian Seubert et al.
HEPATOLOGY (2015)
The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment
Ronit Vogt Sionov et al.
CANCER MICROENVIRONMENT (2015)
Type 2 cytokines: mechanisms and therapeutic strategies
Thomas A. Wynn
NATURE REVIEWS IMMUNOLOGY (2015)
Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
Claire Germain et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma
N. Sunaga et al.
BRITISH JOURNAL OF CANCER (2014)
CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition
Xian-Shuo Cheng et al.
CANCER LETTERS (2014)
CCR7: Roles in cancer cell dissemination, migration and metastasis formation
Daniel F. Legler et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group
Kristen K. Ciombor et al.
INVESTIGATIONAL NEW DRUGS (2014)
CC Chemokine Receptor 6 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma
Feng Liu et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
The SDF-1/CXCR4 axis induces epithelial-mesenchymal transition in hepatocellular carcinoma
Xuqi Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
Naofumi Mukaida et al.
MEDIATORS OF INFLAMMATION (2014)
Decreased Expression of CXCR4 Chemokine Receptor in Bone Marrow after Chemotherapy in Patients with Non-Hodgkin Lymphomas Is a Good Prognostic Factor
Grzegorz Mazur et al.
PLOS ONE (2014)
Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis
Esak Lee et al.
NATURE COMMUNICATIONS (2014)
Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved
Maria Grazia Vizioli et al.
ONCOTARGET (2014)
Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases
Shambhunath Bose et al.
ARCHIVES OF PHARMACAL RESEARCH (2013)
The impact of chemokine receptor CXCR4 on breast cancer prognosis: A meta-analysis
Tong-peng Xu et al.
CANCER EPIDEMIOLOGY (2013)
Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance
Xiao-wei Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Margin-Infiltrating CD20+ BCells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma
Jie-Yi Shi et al.
CLINICAL CANCER RESEARCH (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
M-J Jung et al.
ONCOGENE (2013)
Prognostic Significance of B-Cells and pSTAT3 in Patients with Ovarian Cancer
Chunmei Yang et al.
PLOS ONE (2013)
B Cells Promote Tumor Progression via STAT3 Regulated-Angiogenesis
Chunmei Yang et al.
PLOS ONE (2013)
Immunomonitoring and prognostic relevance of neutrophils in clinical trials
Frede Donskov
SEMINARS IN CANCER BIOLOGY (2013)
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients
Stephen M. Ansell et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Protumoral role of monocytes in human B-cell precursor acute lymphoblastic leukemia: involvement of the chemokine CXCL10
Yunqin Lee et al.
BLOOD (2012)
Directed cell invasion and migration during metastasis
Jose Javier Bravo-Cordero et al.
CURRENT OPINION IN CELL BIOLOGY (2012)
Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis
Huanhuan Joyce Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
High Expression of CX3CL1/CX3CR1 Axis Predicts a Poor Prognosis of Pancreatic Ductal Adenocarcinoma
Xianhui Xu et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas
Liborio Torregrossa et al.
MODERN PATHOLOGY (2012)
CXCR4 Expression in Prostate Cancer Progenitor Cells
Anna Dubrovska et al.
PLOS ONE (2012)
CCL21/CCR7 Prevents Apoptosis via the ERK Pathway in Human Non-Small Cell Lung Cancer Cells
Ying Xu et al.
PLOS ONE (2012)
CCR7-expressing B16 melanoma cells downregulate interferon-γ-mediated inflammation and increase lymphangiogenesis in the tumor microenvironment
T. Takekoshi et al.
ONCOGENESIS (2012)
Mechanisms Regulating the Secretion of the Promalignancy Chemokine CCL5 by Breast Tumor Cells: CCL5's 40s Loop and Intracellular Glycosaminoglycans
Gali Soria et al.
NEOPLASIA (2012)
Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer
Ende Zhao et al.
ONCOIMMUNOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells
Romaine I. Fernando et al.
CANCER RESEARCH (2011)
Maximal T Cell-Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells
Alicia Gonzalez-Martin et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
Yan Ning et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene et al.
NATURE (2011)
Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ TH2 cells
Sabina A. Islam et al.
NATURE IMMUNOLOGY (2011)
Identification of the Chemokine CX3CL1 as a New Regulator of Malignant Cell Proliferation in Epithelial Ovarian Cancer
Francoise Gaudin et al.
PLOS ONE (2011)
Homeostatic chemokine receptors and organ-specific metastasis
Albert Zlotnik et al.
NATURE REVIEWS IMMUNOLOGY (2011)
CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression
Xueqing Sun et al.
CANCER AND METASTASIS REVIEWS (2010)
Lymphocytes in cancer development: Polarization towards pro-tumor immunity
Brian Ruffell et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor
Christine Bolitho et al.
ENDOCRINE-RELATED CANCER (2010)
Regulatory T cells in tumor immunity
Hiroyoshi Nishikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma
Xiaohong Shen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Christophe Ginestier et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice
David J. DiLillo et al.
JOURNAL OF IMMUNOLOGY (2010)
CXCL10 Can Inhibit Endothelial Cell Proliferation Independently of CXCR3
Gabriele S. V. Campanella et al.
PLOS ONE (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer?
Yohannes Mebratu et al.
CELL CYCLE (2009)
CXCR4+FOXP3+CD25+ LYMPHOCYTES ACCUMULATE IN CXCL12-EXPRESSING MALIGNANT PLEURAL MESOTHELIOMA
Y. Shimizu et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)
CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NFκB through the CBM (Carma3/Bcl10/Malt1) Complex
Daniel Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
Marcus C. B. Tan et al.
JOURNAL OF IMMUNOLOGY (2009)
Role of the chemokines CCL3/MIP-1α and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice
Luciola S. Barcelos et al.
MICROVASCULAR RESEARCH (2009)
CXCR4 Expression in Early Breast Cancer and Risk of Distant Recurrence
Fabrice Andre et al.
ONCOLOGIST (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Increased expression of Fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma
Miki Hyakudomi et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Marco Wendel et al.
CANCER RESEARCH (2008)
Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice
Chengwen Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice
Jean-David Bouaziz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis
Jian-Jang You et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway
Zhongxing Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2007)
CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers
Bo Huang et al.
CANCER LETTERS (2007)
Regulation of the actin cytoskeleton in cancer cell migration and invasion
Hideki Yamaguchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation
F. Luppi et al.
LUNG CANCER (2007)
Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma
Takeshi Matsubara et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
CXCR4 is a prognostic marker in acute myelogenous leukemia
Anke C. Spoo et al.
BLOOD (2007)
Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion
David Zagzag et al.
LABORATORY INVESTIGATION (2006)
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion
Yi Lu et al.
PROSTATE (2006)
The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients
Neora Yaal-Hahoshen et al.
CLINICAL CANCER RESEARCH (2006)
Cancer CXC chemokine networks and tumour angiogenesis
RM Strieter et al.
EUROPEAN JOURNAL OF CANCER (2006)
Primary T cell expansion and requires antigen presentation differentiation in vivo by B cells
Alison Crawford et al.
JOURNAL OF IMMUNOLOGY (2006)
Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells
S Brand et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Involvement of chemokine receptor CCR6 in colorectal cancer metastasis
Claudia Rubie et al.
TUMOR BIOLOGY (2006)
Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma
E Ryschich et al.
CANCER RESEARCH (2006)
Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis
J Hwang et al.
CYTOKINE (2005)
Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo
GV Shurin et al.
JOURNAL OF IMMUNOLOGY (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8
R Schruefer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Derangement of immune responses by myeloid suppressor cells
P Serafini et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo
JS Hwang et al.
FEBS LETTERS (2004)
Interleukin-8/CXCL8 is a growth factor for human lung cancer cells
YM Zhu et al.
BRITISH JOURNAL OF CANCER (2004)
BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells
TD Shellenberger et al.
CANCER RESEARCH (2004)
CCL16 activates an angiogenic program in vascular endothelial cells
M Strasly et al.
BLOOD (2004)
Cell migration: Integrating signals from front to back
AJ Ridley et al.
SCIENCE (2003)
Dendritic cells support sequential reprogramming of chemoattractant receptor profiles during naive to effector T cell differentiation
CH Kim et al.
JOURNAL OF IMMUNOLOGY (2003)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
NF-κB, chemokine gene transcription and tumour growth
A Richmond
NATURE REVIEWS IMMUNOLOGY (2002)
Lymphotactin expression by engineered myeloma cells drives tumor regression:: Mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor
CM Cairns et al.
JOURNAL OF IMMUNOLOGY (2001)
Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells
R Salcedo et al.
JOURNAL OF IMMUNOLOGY (2001)
Chemokines in lymphopoiesis and lymphoid organ development
KM Ansel et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Chemokines: A new classification system and their role in immunity
A Zlotnik et al.
IMMUNITY (2000)
Share Paper
